Cover Image

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

Kaisa Taipale,1 Katherine B Winfree,2 Mark Boye,2 Mickael Basson,3 Ghassan Sleilaty,4 James Eaton,5 Rachel Evans,5 Christos Chouaid6 1Global Patient Outcomes and Real World Evidence International, Oy Eli Lilly Finland AB, Helsinki, Finland; 2Global Patient Outcomes and Real World Evidence, Eli Lilly...

Full description

Saved in:

Bibliographic Details
Main Authors:	Taipale K (Author), Winfree KB (Author), Boye M (Author), Basson M (Author), Sleilaty G (Author), Eaton J (Author), Evans R (Author), Chouaid C (Author)
Format:	Book
Published:	Dove Medical Press, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer
by: Himani Aggarwal, et al.
Published: (2023)

Cost-effectiveness analysis of sugemalimab vs. chemotherapy as first-line treatment of metastatic nonsquamous non-small cell lung cancer
by: Zhiwei Zheng, et al.
Published: (2022)

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
by: Chouaïd C, et al.
Published: (2014)

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer in China
by: Liu Qiao, et al.
Published: (2021)

The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
by: Xia Luo, et al.
Published: (2022)

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer
by: Xia Luo, et al.
Published: (2022)

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
by: Vergnenègre A, et al.
Published: (2012)

Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
by: Chen JH, et al.
Published: (2016)

Cost analysis of adverse events associated with non-small cell lung cancer management in France
by: Chouaid C, et al.
Published: (2017)

An Epidemiologic study of Oral and Pharyngeal Nonsquamous Cell Malignant Tumors inKerman province, Iran
by: MR. Zarei, et al.
Published: (2007)

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France
by: Pignata M, et al.
Published: (2017)

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario
by: Flavia A. Duarte, et al.
Published: (2022)

Rapid Sequence Induction
by: Mojca Konia
Published: (2010)

Rotor Drivers in Induction and Maintenance of Atrial Fibrillation
by: A. A. Kulikov, et al.
Published: (2021)

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients
by: Meiyu Fang, et al.
Published: (2012)

Cost-effectiveness Analysis of Rituximab Maintenance Treatment in Patients With Follicular Lymphoma who Respond to First Line Induction Therapy in Portugal
by: Susana Carvalho, et al.
Published: (2016)

Weight-Based Adaptation of TNF-Antagonist Induction versus Maintenance Dose
by: Marco A. Muster, et al.
Published: (2011)

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
by: Vergnenègre A, et al.
Published: (2013)

Induction and Maintenance of Long-Term Immunological Memory Following Infection or Vaccination
Published: (2020)

"Highly Exposed Chinese Herbal Medicine" Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
by: Mingqi Wang, et al.
Published: (2021)

Term induction of labour in nulliparous women: When to draw the line?
by: Jill M. Mitchell, et al.
Published: (2022)

Molecular Mechanism of Neuronal Plasticity: Induction and Maintenance of Long-Term Potentiation in the Hippocampus
by: Eishichi Miyamoto
Published: (2006)

Review of binary, ternary and quaternary mixtures for induction and maintenance of opioid free anesthesia
by: Beatriz Tauste-Hernández, et al.
Published: (2021)

First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020)

In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines
by: Linda Wanika, et al.
Published: (2024)

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe
by: Walleser S, et al.
Published: (2012)

The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions
by: David Campbell, et al.
Published: (2018)

Induction of Apoptosis by Ethyl Acetate Fraction of Astragalus membranaceus in Human Non-small Cell Lung Cancer Cells - Apoptosis Induction by Astragalus membranaceus -
by: Hyun-Ji Park, et al.
Published: (2018)

A Survey of Paediatric Rapid Sequence Induction in a Department of Anaesthesia
by: Lloyd Duncan, et al.
Published: (2022)

SEQUENCE OF BENCHMARKING STAGES FOR SMALL ENTERPRISES
by: Alyona Kos
Published: (2016)

The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis
by: Ching-Chung Ko, et al.
Published: (2023)

Impact of the COVID-19 Pandemic on COPD Patient Mortality: A Nationwide Study in France
by: Jonas Poucineau, et al.
Published: (2024)

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
by: Qin Wang, et al.
Published: (2018)

The Big Five Motorcycle Boys on the Battle Line; Or, With the Allies in France
by: Marlow, Ralph

Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
by: Qiang Zhang, et al.
Published: (2024)

Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004
by: Valin Nadia, et al.
Published: (2010)

Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment
by: Mondher Toumi, et al.
Published: (2017)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
by: Enriqueta Felip, et al.
Published: (2008)

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
by: Serena Ricciardi, et al.
Published: (2009)

Doublet vs Single-Agent Maintenance Therapy in the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Qi J, et al.
Published: (2020)